OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · IEX Real-Time Price · USD
10.12
+1.32 (15.00%)
At close: Apr 26, 2024, 4:00 PM
9.98
-0.14 (-1.38%)
After-hours: Apr 26, 2024, 7:35 PM EDT
OptimizeRx Revenue
In the year 2023, OptimizeRx had annual revenue of $71.52M with 14.53% growth. Revenue in the quarter ending December 31, 2023 was $28.37M with 44.34% year-over-year growth.
Revenue (ttm)
$71.52M
Revenue Growth
+14.53%
P/S Ratio
2.57
Revenue / Employee
$529,789
Employees
135
Market Cap
184.02M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 71.52M | 9.07M | 14.53% |
Dec 31, 2022 | 62.45M | 1.16M | 1.89% |
Dec 31, 2021 | 61.29M | 17.98M | 41.51% |
Dec 31, 2020 | 43.31M | 18.72M | 76.08% |
Dec 31, 2019 | 24.60M | 3.39M | 15.99% |
Dec 31, 2018 | 21.21M | 9.08M | 74.86% |
Dec 31, 2017 | 12.13M | 4.38M | 56.45% |
Dec 31, 2016 | 7.75M | 530.78K | 7.35% |
Dec 31, 2015 | 7.22M | 717.72K | 11.04% |
Dec 31, 2014 | 6.50M | 1.82M | 38.96% |
Dec 31, 2013 | 4.68M | 2.69M | 135.27% |
Dec 31, 2012 | 1.99M | 877.57K | 78.95% |
Dec 31, 2011 | 1.11M | 1.04M | 1,464.09% |
Dec 31, 2010 | 71.07K | 44.34K | 165.93% |
Dec 31, 2009 | 26.72K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
P3 Health Partners | 1.27B |
Inogen | 315.66M |
Quipt Home Medical | 185.18M |
Scilex Holding Company | 46.74M |
ProQR Therapeutics | 10.58M |
Orchestra BioMed Holdings | 2.76M |
OPRX News
- 19 hours ago - OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET - GlobeNewsWire
- 8 days ago - OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report - GlobeNewsWire
- 10 days ago - OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 15 days ago - OptimizeRx Named America's Fastest-Growing Company for Fifth Year in a Row - GlobeNewsWire
- 4 weeks ago - OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET - GlobeNewsWire
- 6 weeks ago - OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023 - GlobeNewsWire
- 7 weeks ago - OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community' Outreach Effort - GlobeNewsWire
- 2 months ago - OptimizeRx to Participate in Upcoming Investor Conferences - GlobeNewsWire